Our research into myeloma
120 years of life-saving discoveries
Our scientists have been at the forefront of cancer research since 1902.
Thanks to you, we’ve come so far. And we will go much further.
Together, we will beat cancer.
Our research is saving lives
Myeloma is a cancer that starts from immune cells in the bone marrow. Around 15 people are diagnosed with the disease each day. Survival is improving all the time – a third of people will now survive their disease for at least 10 years. But we know we need to do better, so our researchers are working hard to save more lives, now and in the future.
Current research
From studying the biology of myeloma cells in the lab to leading clinical trials testing cutting-edge treatments, our researchers are working hard to ensure more people survive myeloma.
Past research
Thanks to research, we’ve helped change the outlook for people with myeloma.
Patients' stories
Meet people like Heather who have experienced first-hand how our research is making a difference. The life-saving research we do wouldn’t be possible without your support.
Further information
Our strategy
Over the last 40 years, cancer survival in the UK has doubled. In the 1970s just 1 in 4 people survived their disease for 10 years or more. Today 2 in 4 survive.
We want to accelerate progress and see 3 in 4 patients surviving the disease by 2034.